|
|
Volumn 12, Issue 2, 1997, Pages 175-182
|
|
The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: An interim analysis of a Norwegian-Danish 5-year study
|
|
Author keywords
Levodopa; Parkinson's disease; Selegiline; Therapy
|
|
Indexed keywords
ANTIPARKINSON AGENT;
LEVODOPA;
MONOAMINE OXIDASE INHIBITOR;
SELEGILINE;
ADULT;
AGED;
ARTICLE;
CANCER;
CEREBROVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DENMARK;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HALLUCINATION;
HUMAN;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
NORWAY;
PARKINSON DISEASE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SIDE EFFECT;
TIME;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIPARKINSON AGENTS;
DENMARK;
DISABILITY EVALUATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LEVODOPA;
LONG-TERM CARE;
MALE;
MIDDLE AGED;
NEUROLOGIC EXAMINATION;
NORWAY;
PARKINSON DISEASE;
SELEGILINE;
|
|
EID: 0030899733
PISSN: 08853185
EISSN: None
Source Type: Journal
DOI: 10.1002/mds.870120207 Document Type: Article |
|
Times cited : (36)
|
|
References (6)
|
